Afya (NASDAQ:AFYA) VP De Sousa Anibal Jose Grifo Sells 14,000 Shares

Afya Limited (NASDAQ:AFYA) VP De Sousa Anibal Jose Grifo sold 14,000 shares of the stock in a transaction that occurred on Monday, April 13th. The stock was sold at an average price of $15.41, for a total value of $215,740.00. Following the transaction, the vice president directly owned 31,000 shares in the company, valued at approximately $477,710. This represents a 31.11% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

De Sousa Anibal Jose Grifo also recently made the following trade(s):

• On Tuesday, April 7th, De Sousa Anibal Jose Grifo sold 5,000 shares of Afya stock. The stock was sold at an average price of $15.20, for a total value of $76,000.00.

Afya Stock Performance

NASDAQ:AFYA traded down $0.20 during trading hours on Tuesday, reaching $15.46. 64,289 shares of the stock were exchanged, compared to its average volume of 117,213. The company has a quick ratio of 2.20, a current ratio of 2.20 and a debt-to-equity ratio of 0.41. The firm has a 50 day simple moving average of $14.49 and a 200-day simple moving average of $14.67. Afya Limited has a 52 week low of $13.00 and a 52 week high of $19.90. The stock has a market capitalization of $1.45 billion, a P/E ratio of 10.59, a P/E/G ratio of 0.67 and a beta of 0.48.

Afya (NASDAQ:AFYA) last announced its quarterly earnings results on Wednesday, March 11th. The company reported $0.41 earnings per share for the quarter, topping analysts’ consensus estimates of $0.36 by $0.05. The business had revenue of $147.08 million for the quarter, compared to analysts’ expectations of $174.74 million. Afya had a return on equity of 18.77% and a net margin of 20.31%. As a group, sell-side analysts forecast that Afya Limited will post 1.52 earnings per share for the current fiscal year.

Afya Dividend Announcement

The business also recently declared an annual dividend, which was paid on Monday, April 6th. Stockholders of record on Wednesday, March 25th were given a dividend of $0.656 per share. This represents a dividend yield of 433.0%. The ex-dividend date was Wednesday, March 25th. Afya’s dividend payout ratio is presently 44.52%.

Institutional Trading of Afya

Several large investors have recently added to or reduced their stakes in AFYA. Daiwa Securities Group Inc. acquired a new stake in Afya in the 4th quarter valued at approximately $43,000. Militia Capital Partners LP acquired a new stake in Afya in the 2nd quarter valued at approximately $71,000. Quantbot Technologies LP acquired a new stake in Afya in the 2nd quarter valued at approximately $117,000. Van ECK Associates Corp increased its position in shares of Afya by 15.7% during the 3rd quarter. Van ECK Associates Corp now owns 10,170 shares of the company’s stock valued at $159,000 after purchasing an additional 1,377 shares during the period. Finally, State of Wyoming acquired a new position in shares of Afya during the 2nd quarter valued at $164,000. 88.02% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

AFYA has been the topic of a number of research reports. Bank of America cut Afya from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $22.00 to $17.00 in a research report on Tuesday, February 24th. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $22.00 price target (down from $24.50) on shares of Afya in a research report on Wednesday, January 7th. Zacks Research upgraded Afya from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, April 7th. UBS Group restated a “neutral” rating and issued a $16.00 target price (down from $18.00) on shares of Afya in a research report on Friday, January 16th. Finally, Sanford C. Bernstein upgraded Afya to a “market perform” rating in a research report on Friday, January 16th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $17.30.

Afya Company Profile

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.